Journal of Surgical Oncology最新文献

筛选
英文 中文
The Impact of Intraoperative Anesthesiology Provider Handovers on Postoperative Complications After Hepatopancreatobiliary (HPB) Surgery. 术中麻醉医师交接对肝胆胰 (HPB) 手术术后并发症的影响。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-10 DOI: 10.1002/jso.27941
Juan Jose Guerra-Londono, Sydney Pham, Neal Bhutiani, Laura Prakash, Lei Feng, Ching-Wei D Tzeng, Juan P Cata, Jose M Soliz
{"title":"The Impact of Intraoperative Anesthesiology Provider Handovers on Postoperative Complications After Hepatopancreatobiliary (HPB) Surgery.","authors":"Juan Jose Guerra-Londono, Sydney Pham, Neal Bhutiani, Laura Prakash, Lei Feng, Ching-Wei D Tzeng, Juan P Cata, Jose M Soliz","doi":"10.1002/jso.27941","DOIUrl":"https://doi.org/10.1002/jso.27941","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study is to assess the possible association between intraoperative anesthesia team handovers and increased 90-day major complications following HPB surgery.</p><p><strong>Methods: </strong>This is a single-center retrospective cohort study of patients who underwent HPB surgery. Anesthesiologist handover (AH) occurred when a complete transfer of care to a receiving anesthesiologist. total anesthesia team handovers (TH) occurred when both anesthesiologist and supervised provider transferred care. The primary outcome was 90-day major complications, defined as an ACCORDION score of ≥ 3.</p><p><strong>Results: </strong>Ninety-day major complications occurred in 35 (21.6%) of TH and 96 (21.9%) of AH patients. With adjustment of other covariates, no significant association was found between AH (OR, 1.358, 95% CI, 0.935-1.973, p = 0.1079) or TH (OR, 1.157, 95% CI, 0.706-1.894, p = 0.5633) and 90-day major complications.</p><p><strong>Conclusions: </strong>In a high-volume HPB center, anesthesia team handovers were not associated with an increased risk of patients having a major complication within 90 days after HPB surgery.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Preoperative Counseling and Education on Decreasing Anxiety in Patients With Gynecologic Tumors: A Randomized Clinical Trial. 术前咨询和教育对减轻妇科肿瘤患者焦虑的影响:随机临床试验
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-08 DOI: 10.1002/jso.27942
Milena Roberta Teixeira, Gabriela da Silva Oliveira, Carlos Eduardo Mattos Cunha Andrade, Ronaldo Luis Schmidt, Valiana Alves Teodoro, Priscila Grecca Pedrão, Glauco Baiocchi, Carlos Eduardo Paiva, Ricardo Dos Reis
{"title":"Impact of Preoperative Counseling and Education on Decreasing Anxiety in Patients With Gynecologic Tumors: A Randomized Clinical Trial.","authors":"Milena Roberta Teixeira, Gabriela da Silva Oliveira, Carlos Eduardo Mattos Cunha Andrade, Ronaldo Luis Schmidt, Valiana Alves Teodoro, Priscila Grecca Pedrão, Glauco Baiocchi, Carlos Eduardo Paiva, Ricardo Dos Reis","doi":"10.1002/jso.27942","DOIUrl":"https://doi.org/10.1002/jso.27942","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the impact of counseling and preoperative education on reducing anxiety in patients undergoing surgery for gynecologic cancer.</p><p><strong>Methods: </strong>In this randomized clinical trial, patients with gynecological tumors undergoing surgical treatment between 15 and 60 days preoperatively, were included. The group was randomized to receive preoperative routine orientation plus preoperative counseling and education by nursing (experimental group [EG]) or receive preoperative routine orientation only (control group [CG]). We stratified the groups by surgical approach: open, laparoscopy, and robotic. We excluded patients treated in another service and with the need for an intensive care unit after surgery. We used the Hospital Anxiety and Depression Scale (HADS) to evaluate symptoms of anxiety and depression. The severity of symptoms was evaluated using the Edmonton Symptom Assessment System (ESAS-Br).</p><p><strong>Results: </strong>We analyzed 54 women (CG 27, EG 27). No significant differences were observed regarding ESAS scores (total, physical, emotional, well-being, and anxiety) between preoperative and postoperative evaluation. However, in the EG, comparing the preoperative versus postoperative moments, there was a significant reduction in total, emotional, and anxiety scores of ESAS (p = 0.012; p = 0.003; p = 0.001). No difference in anxiety symptoms by HADS scale was noted between the two groups, comparing preoperative and postoperative moments, CG (40.7% and 22.2%) and EG (37.0% and 25.9%) (p = 0.78; p = 0.75), respectively. Also, in depression symptoms (HADS scale), we found no difference comparing preoperative and postoperative moments (p = 0.34; p > 0.99). When we stratified by surgical approach or time between intervention and surgery ( ≤ 15, > 15 to ≤ 30, and > 30 days), no difference was observed in the anxiety and depression symptoms evaluation, in both groups.</p><p><strong>Conclusions: </strong>The preoperative education by nurse orientation reduced the total, emotional, and anxiety symptoms of ESAS score between preoperative and postoperative moments. However, by the HADS scale, there was no difference in anxiety and depression symptoms.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment On: "Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer". 评论:"乳腺癌遗传易感性妇女预防性手术干预的影响因素"。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-08 DOI: 10.1002/jso.27930
Chenye Liu, Hua Zhao, Yuejun Zhou
{"title":"Comment On: \"Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer\".","authors":"Chenye Liu, Hua Zhao, Yuejun Zhou","doi":"10.1002/jso.27930","DOIUrl":"https://doi.org/10.1002/jso.27930","url":null,"abstract":"","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overall survival and prognostic factors associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with intraoperative radiation therapy in patients with advanced abdominopelvic malignancies: A single center retrospective analysis of 159 patients. 晚期腹盆腔恶性肿瘤患者接受细胞切除手术和腹腔内热化疗联合术中放疗后的总生存率和预后因素:对159例患者的单中心回顾性分析。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-04 DOI: 10.1002/jso.27791
Marwan Alaswad, Tarek Z Arabi, Ziad Alhosainy, Juman Alammar, Ayman Z Azzam, Tarek M Amin
{"title":"Overall survival and prognostic factors associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with intraoperative radiation therapy in patients with advanced abdominopelvic malignancies: A single center retrospective analysis of 159 patients.","authors":"Marwan Alaswad, Tarek Z Arabi, Ziad Alhosainy, Juman Alammar, Ayman Z Azzam, Tarek M Amin","doi":"10.1002/jso.27791","DOIUrl":"https://doi.org/10.1002/jso.27791","url":null,"abstract":"<p><strong>Background and objectives: </strong>The aim of this study was to look at the overall survival (OS), progression-free survival (PFS), and prognostic factors associated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) combined with intraoperative radiation therapy (IORT).</p><p><strong>Methods: </strong>This study is a single center retrospective study performed on 159 patients who underwent treatment with CRS and HIPEC combined with IORT for abdominopelvic malignancies. OS and PFS were used to evaluate the efficacy of this treatment strategy amongst patients with abdominopelvic malignancies.</p><p><strong>Results: </strong>The cohort's median age was 53 years, with a male predominance (58.5%). The median OS was not reached, but the mean OS was 76.87 months. In univariate analysis, several factors, including synchronous organ metastasis, Pathologic Peritoneal Carcinomatosis Index (pPCI) ≥10, increased estimated blood loss, and severe postoperative complications, were associated with worse OS. However, multivariate analysis identified pPCI ≥ 10 as the sole independent predictor of worse OS. The 1- and 3-year survival rates were 83% and 70.4%, respectively. pPCI ≥ 10 and severe postoperative complications were significant predictors of worse survival outcomes.</p><p><strong>Conclusions: </strong>Radical surgery alone is not enough, and CRS combined with HIPEC and IORT, when indicated, was proven to be safe and effective with no added morbidity or mortality.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Care Patterns and Outcomes for Intrahepatic Cholangiocarcinoma by Rurality of Patient Residence in a Midwestern State. 中西部某州按患者居住地的偏远程度划分的肝内胆管癌护理模式和疗效。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-04 DOI: 10.1002/jso.27939
Mohammed O Suraju, Darren M Gordon, Amanda R Kahl, Ana McCracken, Erica Maduokolam, Jordan Grimmett, Komlan Guedeze, Sarah Nash, Aziz Hassan
{"title":"Care Patterns and Outcomes for Intrahepatic Cholangiocarcinoma by Rurality of Patient Residence in a Midwestern State.","authors":"Mohammed O Suraju, Darren M Gordon, Amanda R Kahl, Ana McCracken, Erica Maduokolam, Jordan Grimmett, Komlan Guedeze, Sarah Nash, Aziz Hassan","doi":"10.1002/jso.27939","DOIUrl":"https://doi.org/10.1002/jso.27939","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy of the liver and has the worst prognosis of any tumor arising from the liver, with a 5-year survival as low as 10%. However, whether the rurality of a patient's residence impacts care received and survival has not been well studied. We aimed to assess differences in care patterns associated with the rurality of patient's residences and their impact on survival outcomes, hypothesizing that patients in rural areas would experience lower survival.</p><p><strong>Methods: </strong>Adult patients diagnosed with ICC between 2010 and 2020 were identified in the Iowa Cancer Registry. Chi-square tests were used to compare values categorical variables by rural/urban status. Cox proportional hazards regression was used to determine associations with cancer-specific mortality.</p><p><strong>Results: </strong>Of 672 patients diagnosed with ICC during the study period, 53%, 27%, and 21% resided in metropolitan, micropolitan, and rural areas, respectively. There were no significant differences in age, sex, stage at diagnosis, the proportion receiving chemotherapy within 12 weeks of diagnosis, and undergoing surgery across all groups. Additionally, the proportion receiving definitive care at a National Cancer Institute (NCI) designated center was comparable across the three groups (37% metro vs. 43% micro vs. 35% rural). However, rural residents had the highest proportion of traveling ≥ 50 miles for definitive care (22% metro vs. 41% micro vs. 56% rural). In multivariable analysis of patients with Stage 1-3 disease, younger age, receipt of chemotherapy, surgery, and definitive care at an NCI center were independently associated with decreased mortality risk. However, rural residence was not significantly associated with survival (HR: 0.64 [95% CI: 0.38-1.06]).</p><p><strong>Conclusion: </strong>Similar to other complex cancer diagnoses, we found that definitive care at an NCI center was associated with decreased mortality risk for patients with ICC. Although rural residence was not independently associated with survival in this cohort, rural residents traveled significantly longer distances to access definitive care. This highlights a crucial need to improve access to specialized centers for complex cancer care.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models. 开发腹膜假性肌瘤类器官模型的组合培养策略
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-03 DOI: 10.1002/jso.27850
Luca Varinelli, Marzia Di Bella, Marcello Guaglio, Davide Battistessa, Federica Pisati, Tommaso Cavalleri, Massimo Milione, Jordi Martínez-Quintanilla, Patrick T Caswell, Dario Baratti, Shigeki Kusamura, Marcello Deraco, Manuela Gariboldi
{"title":"A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models.","authors":"Luca Varinelli, Marzia Di Bella, Marcello Guaglio, Davide Battistessa, Federica Pisati, Tommaso Cavalleri, Massimo Milione, Jordi Martínez-Quintanilla, Patrick T Caswell, Dario Baratti, Shigeki Kusamura, Marcello Deraco, Manuela Gariboldi","doi":"10.1002/jso.27850","DOIUrl":"https://doi.org/10.1002/jso.27850","url":null,"abstract":"<p><strong>Background and objectives: </strong>Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics. The aim of the study is to develop a culture strategy to generate organoid models derived from PMP patient samples.</p><p><strong>Methods: </strong>We followed a strategy based on combinatorial culture conditions that include the different factors essential for PMP growth and that mimic the microenvironment present in the patients.</p><p><strong>Results: </strong>We cultured PMP samples in the presence of the various factors produced by the niche environment of PMP. We obtained 12 PMP organoid models, each of which grows under specific culture conditions. PMP-derived organoids show long-term expansion capacity and reproduce the genetic landscape and histological phenotype of the tumor of origin.</p><p><strong>Conclusion: </strong>The organoids we developed faithfully reproduce the key features of PMP disease and will allow us to understand the biology of PMP. With them, we will be able to identify key regulatory networks that support PMP progression, providing a platform for multilevel preclinical testing, identify novel diagnostic biomarkers, and generate novel targets for patient treatments.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma: A National Cohort Study. 可手术临床 III 期黑色素瘤的免疫疗法排序与疗效:一项全国队列研究。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-03 DOI: 10.1002/jso.27933
Anushka Dheer, Gabriella N Tortorello, Neha Shafique, Mohammad S Farooq, Tara C Mitchell, Xiaowei Xu, John T Miura, Giorgos C Karakousis
{"title":"Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma: A National Cohort Study.","authors":"Anushka Dheer, Gabriella N Tortorello, Neha Shafique, Mohammad S Farooq, Tara C Mitchell, Xiaowei Xu, John T Miura, Giorgos C Karakousis","doi":"10.1002/jso.27933","DOIUrl":"https://doi.org/10.1002/jso.27933","url":null,"abstract":"<p><strong>Background and objectives: </strong>The impact of neoadjuvant immunotherapy (NIT) on overall survival (OS) in patients with resectable stage III melanoma remains unknown. We sought to identify factors associated with receipt of NIT and survival outcomes in patients with clinical stage III melanoma undergoing surgery.</p><p><strong>Methods: </strong>The National Cancer Database (2016-2020) was used to identify patients with clinical stage III melanoma who underwent surgery and received either NIT or adjuvant immunotherapy (AIT) only. Multivariable regression, Kaplan-Meier, and Cox proportional hazard methods were used to analyze variables of interest.</p><p><strong>Results: </strong>Patients with clinical N3 disease had 2.5 times the odds of NIT compared to those with N1 disease (95% CI 1.74-3.49). There was no difference in 3-year OS between the two cohorts: 79% (95% CI 73%-85%) for NIT patients and 75% (95% CI 73%-76%) for AIT patients (p = 0.078). Patients with N2/N3 disease had improved 3-year OS of 79% with NIT versus 71% for AIT-only (HR 0.61, 95% CI 0.38-0.97, p = 0.037).</p><p><strong>Conclusions: </strong>NIT is given more selectively to clinical stage III patients with more advanced N category disease. Despite significant differences in N category between groups, there was no difference in OS observed at 3 years, and NIT was associated with a survival advantage among N2/N3 patients.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "The Effect of Radiation or Chemotherapy on the Local Recurrence, Overall Survival, and Distant Metastasis in Patients With Myxofibrosarcoma: A Systematic Review". 关于 "放疗或化疗对肌纤维肉瘤患者局部复发、总生存期和远处转移的影响:系统综述
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-02 DOI: 10.1002/jso.27938
Navneet Jain, Muhammed Shabil, Sanjit Sah
{"title":"Comment on \"The Effect of Radiation or Chemotherapy on the Local Recurrence, Overall Survival, and Distant Metastasis in Patients With Myxofibrosarcoma: A Systematic Review\".","authors":"Navneet Jain, Muhammed Shabil, Sanjit Sah","doi":"10.1002/jso.27938","DOIUrl":"https://doi.org/10.1002/jso.27938","url":null,"abstract":"","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Health Outcomes in Surgical Oncology. 肿瘤外科健康结果的差异。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-02 DOI: 10.1002/jso.27891
Shaneeta M Johnson, Kimberly Miller-Hammond, Tamra McKenzie-Johnson, John Stewart
{"title":"Disparities in Health Outcomes in Surgical Oncology.","authors":"Shaneeta M Johnson, Kimberly Miller-Hammond, Tamra McKenzie-Johnson, John Stewart","doi":"10.1002/jso.27891","DOIUrl":"https://doi.org/10.1002/jso.27891","url":null,"abstract":"<p><p>Cancer health disparities refer to the unequal burden, treatment, and outcomes of cancer care experienced by specific populations. These disparities are systemic and often preventable, impacting diverse populations, including racial and ethnic minorities, medically underserved populations, populations in rural areas, individuals from the LGBT communities, disabled persons, extremes of age, and those living in persistent poverty. Addressing this topic is essential and timely to ensure equitable oncologic outcomes for all populations. Experts in surgical oncology and health disparities have collaborated to produce this seminar issue on Disparities in Surgical Oncology.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Machine Learning Models for Predicting the 1-Year Risk of Reoperation After Lower Limb Oncological Resection and Endoprosthetic Reconstruction Based on Data From the PARITY Trial. 基于 PARITY 试验数据开发机器学习模型,用于预测下肢肿瘤切除术和假体内重建术后 1 年的再手术风险。
IF 2 3区 医学
Journal of Surgical Oncology Pub Date : 2024-10-02 DOI: 10.1002/jso.27937
Ying Yang, Qiang Hu
{"title":"Development of Machine Learning Models for Predicting the 1-Year Risk of Reoperation After Lower Limb Oncological Resection and Endoprosthetic Reconstruction Based on Data From the PARITY Trial.","authors":"Ying Yang, Qiang Hu","doi":"10.1002/jso.27937","DOIUrl":"https://doi.org/10.1002/jso.27937","url":null,"abstract":"","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信